18 and older, any sex, with Diabetic Retinopathy or Diabetic Blindness. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Number of Participant Who Had Baseline Eye ExamPrimary· baseline
The number of participants who had their baseline eye exam will be determined using the electronic health record
Group
Value
95% CI
Intervention Arm
33
Percentage of Participants Who Completed a Follow-up Eye Exam 12-18 Months After Baseline Eye ExamPrimary· up to 18 month
Percentage of participants who completed a follow-up eye exam 12-18 months after baseline eye exam will be determined using the electronic health record
Group
Value
95% CI
Intervention Arm
71
Sponsor's own description
This is a pilot study of a patient navigator intervention for people living with diabetes and at high risk of diabetic blindness. The investigators are assessing the feasibility and acceptability of the intervention in preparation for a clinical trial.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
NCT07332312 — A Culturally Informed Patient Navigation Program (CFPN) to Reduce Delays Between Diagnosis and Treatment in American Ind
· NA
· not yet recruiting
NCT07176000 — Tailored Patient Navigation to Improve the Uptake of Lung Cancer Screening in Tribal Communities in Western Washington S
· NA
· not yet recruiting
NCT07091617 — Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
· NA
· recruiting
NCT06995924 — Improving Uptake of Surveillance in Colorectal Cancer Survivors Through Navigation and Web Education
· NA
· recruiting
NCT07052630 — Patient Navigation and the Planning Advance Care Together Website to Improve Goals of Care Conversations in Hematopoieti
· NA
· recruiting
Other recruiting trials for Diabetic Retinopathy
Currently open trials in the same condition.
NCT07255326 — Effect of Omega-3 Fatty Acids on Eye Blood Vessels in Type 1 Diabetes
· NA
· recruiting
NCT06782997 — Performance of the Electroretinogram, Performed and Interpreted by an Advanced Practice Nurse, in the Screening for Diab
· recruiting
NCT07002372 — Effect of Video Viewing on Intravitreal Injection Experience
· NA
· recruiting
NCT06713720 — Remote Ischemic Conditioning for Non-Proliferative Diabetic Retinopathy
· NA
· recruiting
NCT06892353 — AI-Powered DIY Screening System for Diabetic Retinopathy
· NA
· recruiting
Other Yale University trials
Trials by the same sponsor.
NCT06900998 — Pilot Study: Effects of Nimodipine on Alcohol Drinking
· Phase 2
· not yet recruiting
NCT04910984 — Developing a Chatbot to Promote HIV Testing
· NA
· not yet recruiting
NCT07458087 — Accuracy of the Accuro 3S
· NA
· not yet recruiting
NCT07398404 — A Multiple Health Behavior Change (MHBC) Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Pa
· Phase 1, PHASE2
· not yet recruiting
NCT07305324 — Improving Liver Fibrosis Diagnosis in Primary Care Using FibroX AI
· NA
· not yet recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Yale University
Last refreshed: 11 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05188703.